Tickerplace logo

Tickerplace

Australian Clinical Labs Limited logo

ACLAustralian Clinical Labs Limited

ACL Stock Price, Valuation & Chart | Australian Clinical Labs Limited

Compare
$2.860+0.02 (+0.70%)

At close · 16 Oct 2026, 05:10 am

Sector: HealthcareIndustry: Medical - Diagnostics & ResearchWebsite
OverviewFinancialsDividendsRatios

ACL Historical price chart

ACL Key Stats

Market Capitalization533.44M
PE Ratio22.89
EPS0.12
Trading Volume119.56K
Today's High/Low2.88/2.85
Dividend Yield5.52
52 Week High/Low3.03/1.83
Shares Outstanding186.52M
ACL Financial Statement

ACL Analyst ratings

Neutral

Strong buy
0
Buy
2
Hold
6
Sell
0
Strong sell
0

Based on 8 analysts giving stock ratings to ACL in the past 3 months.

ACL Analysis & performance metrics

ACL Company profile

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular…

ACL Management team

Management
Joe GeranCTO
National Marketing Director
Eleanor Padman B.A., FCIS
Company Secretary
Matthew CordingleyCFO
Chief Financial Officer
Sean JacksonCTO
Chief Information Officer
Anthony FriedliCOO
Chief Operating Officer
Associate Prof. Tony LandgrenCTO
National Medical Director & Chief Pathologist
Darren McKeeCEO
Chief Executive Officer of Victoria
Shae SeymourCEO
Chief Executive Officer of WA/SA/NT
Total 8 executives

ACL Frequently asked questions

What is Australian Clinical Labs Limited (ACL) Stock Price?

Current stock price of Australian Clinical Labs Limited (ACL) stock is $2.860. The stock price is +0.70% higher in the session. The intraday range can be seen from this page. Volume of Australian Clinical Labs Limited (ACL) stock is 119.56K.

Last updated at 16 Oct 2026, 05:10 am.

Why is the Australian Clinical Labs Limited (ACL) stock price going up or down today?

The stock price of Australian Clinical Labs Limited (ACL) can change with earnings, company news, and overall market sentiment. Australian Clinical Labs Limited operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Australian Clinical Labs Limited stock expensive at its current price?

Whether Australian Clinical Labs Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ACL on this page is 22.89. EPS on this page is 0.12. Compare those figures with peers and growth expectations before deciding if the current Australian Clinical Labs Limited price is justified.

How has the stock price of Australian Clinical Labs Limited (ACL) performed historically?

Historical performance for Australian Clinical Labs Limited (ACL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ACL reacted to past earnings and market events.

Should I buy Australian Clinical Labs Limited (ACL) stock, at this price?

Buying Australian Clinical Labs Limited (ACL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.